Our mission
is to serve greater longevity and prevent heart disorders for elevated heart risk groups through innovative and clinically proven predictive algorithms
Founders
Anna Starynska
Chief Executive Officer
Has MS in Computer & Data Science and is an impeccable project manager with more than 25 years of experience in leading multinational complex projects, such as the European Commission initiative for the 15 Nuclear Power Plants maintenance optimization and the Global Tuberculosis Fund projects management. She is a natural leader, truly passionate about improving heart health, and a serial entrepreneur who bootstrapped the company with her life savings.
Read more
Illya Chaikovsky
Chief Science Officer
MD, multiple Ph.D. with more than 30 years of practicing in cardiology. He's the globally-renowned scientist, whose invaluable experience gained at the Institute of Cybernetics, the Ukrainian Academy of Science, his German Radgein University Ph.D. work, and multiple pieces of research form the core of Cardiolyse CE-certified ECG processing algorithms and patents. Illya is leading an advisory council of PhDs in Cardiology, Cybernetics, Neural Networks, and Data Science, that together with the development team are constantly improving and further clinically validating our algorithms.
Read moreTimeline
Q2
Company launch
Q3
First algorithms finalized and web-platform developed
Q4
Oxford University and China Kadoorie Biobank ongoing validation project start
Q2
Patents for Method of ECG Evaluation Based on Universal ECG Scoring System filed
Q4
The ongoing pilot on CVD remote heart health monitoring in India starts
Q4
Fatigue Risk Management proof of concept for liability insurance launched
Q2
Company brand update, Heart Health monitoring Android and iOS app update
Stay tuned for our news
Science
National Library of Medicine
Electrocardiogram scoring beyond the routine analysis: subtle changes matters
Read more
Cardiolyse Review Article
Prevalence, Risk Factors and Risk Stratification of Cardiovascular Diseases in Patients with Diabetes Mellitus
Read more
Austin Cardiology
Interrelation of the Level of Fatigue and the Parameters of the Energy Supply of Activity for Medical Workers
Read more
IEEE Xplore
Investigation of the ECG leads sensitivity to Myocardial Ischemia by Means of Biophysical Model
Read moreHighlights
2020
CE certification
SX 60145511 0001 class 2a
2019
Top-10 Ukrainian-UK startup contest winner
2018
Top-100 Startups at Slush, Finland
2018
Alumni of Startupbootcamp Digital Health, Berlin
2017
Seal of Excellence certificate from European Commission
2017
GE Healthcare Innovation Village Resident
2016
Selected participant of Novartis HealthTech Lab at Vivatech
2016
Selected participant at TechCrunch SF
Investment
We've successfully raised €600К+ for Cardiolyse’s initial platform development, market research, and clinical trials, along with the first successful pilots with the world's key players from the insurance and pharma sectors, hospital inpatient and outpatient units.
Read moreCardiolyse has opened its last seed investment round now to grow exponentially, conduct cardiovascular disease prevention researches of global value, maintain further clinical trials and develop next product features of patients' and healthcare providers' value while enhancing our team with the robust talent to tackle emerging challenges and obtaining certifications for the next markets entry.
Find out more about Cardiolyse investment opportunities
to join the healthcare digital transformation movement and leave your lasting footprint in cardio diagnostics advancement
Send us a word regarding any question or suggestion you have
Let’s work together
on heart health improvement